Boston Scientific (BSX) Net Income towards Common Stockholders Growth (1y) (2010 - 2026)
Boston Scientific (BSX) Net Income towards Common Stockholders Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 18.55% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 98.96% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 89.28% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -30.10% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 121.14% |
| 10 | Steris | 21.47 Bn | 21.03 Bn | 697.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 98.96% |
| Dec 31, 2025 | 18.94% |
| Sep 30, 2025 | 60.98% |
| Jun 30, 2025 | 145.99% |
| Mar 31, 2025 | 36.16% |
| Dec 31, 2024 | 11.88% |
| Sep 30, 2024 | -7.13% |
| Jun 30, 2024 | 24.14% |
| Mar 31, 2024 | 65.00% |
| Dec 31, 2023 | 300.79% |
| Sep 30, 2023 | 190.23% |
| Jun 30, 2023 | 6.10% |
| Mar 31, 2023 | 209.28% |
| Dec 31, 2022 | 57.50% |
| Sep 30, 2022 | -57.04% |
| Jun 30, 2022 | 43.02% |
| Mar 31, 2022 | -70.34% |
| Dec 31, 2021 | -59.18% |
| Sep 30, 2021 | 339.64% |
| Jun 30, 2021 | 212.42% |